-transparent.png){kind=logo}
The genotoxic and mutagenic activation of promutagens by human fetal livers was measured by the induction of umu gene expression in Salmonella typhimurium TA1535/pSk1002. Liver homogenates of human fetuses were the most active for the mutagenic activation of aflatoxin B1 (AFB1), followed by 2-amino-3-methylimidazo(4,5-f)quinoline (IQ), and to a lesser extent by 2-amino-6-methyldipyrido(1,2-a:3',2'-d)imidazole (Glu-P-1). The amounts of P-450 HFLa immunochemically determined in human fetal livers correlated highly with the induction of umu gene expression by AFB1 (r = 0.98, n = 5). P-450 HFLa catalyzed the mutagenic activation of AFB1 in a reconstituted system: cytochrome b5 markedly stimulated the activation. Anti-P-450 HFLa antibodies inhibited the mutagenic activation of AFB1 in a dose-dependent manner. These results strongly support the idea that P-450 HFLa is responsible for the mutagenic activation of AFB1 in human fetal livers.
M Kitada, and
M Taneda, and
H Ohi, and
M Komori, and
K Itahashi, and
M Nagao, and
T Kamataki
March 1991,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
M Kitada, and
M Taneda, and
H Ohi, and
M Komori, and
K Itahashi, and
M Nagao, and
T Kamataki
June 1986,
Mutation research,
M Kitada, and
M Taneda, and
H Ohi, and
M Komori, and
K Itahashi, and
M Nagao, and
T Kamataki
February 1987,
Biochemical pharmacology,
M Kitada, and
M Taneda, and
H Ohi, and
M Komori, and
K Itahashi, and
M Nagao, and
T Kamataki
July 1988,
Archives of biochemistry and biophysics,
M Kitada, and
M Taneda, and
H Ohi, and
M Komori, and
K Itahashi, and
M Nagao, and
T Kamataki
October 1987,
Toxicology and applied pharmacology,
M Kitada, and
M Taneda, and
H Ohi, and
M Komori, and
K Itahashi, and
M Nagao, and
T Kamataki
October 1987,
The Journal of biological chemistry,
M Kitada, and
M Taneda, and
H Ohi, and
M Komori, and
K Itahashi, and
M Nagao, and
T Kamataki
September 1985,
Biochemical and biophysical research communications,
M Kitada, and
M Taneda, and
H Ohi, and
M Komori, and
K Itahashi, and
M Nagao, and
T Kamataki
October 1988,
Research communications in chemical pathology and pharmacology,
M Kitada, and
M Taneda, and
H Ohi, and
M Komori, and
K Itahashi, and
M Nagao, and
T Kamataki
August 1989,
Journal of biochemistry,
M Kitada, and
M Taneda, and
H Ohi, and
M Komori, and
K Itahashi, and
M Nagao, and
T Kamataki
March 1982,
Cancer research,
